Efficacy of Active Charcoal and Mannitol in Patients with Haff Disease Caused by the Consumption of Crayfish (Procambarus clarkii): A Retrospective Cohort Study
Table 1
Demographic and clinical characteristics of Haff disease patients.
Variable
ACM group (n = 22)
Non-ACM group (n = 46)
value
Age (years)
34.4 ± 9.9
33.6 ± 8.1
0.731
Gender (male/female)
0.392
BMI (kg/m2)
21.2 ± 1.5
21.5 ± 1.5
0.389
Time from crayfish eaten to symptom onset (hours)
3.4 ± 1.7
3.9 ± 2.0
0.296
Duration of hospital stays (days)
7.5 (6.0–8.0)
8.0 (6.8–10.0)
0.032
Symptoms
Myalgia
22
46
Shortness of breath
6
7
0.237
Nausea or vomiting
5
4
0.11
Abdominal pain
4
3
0.139
Weakness
22
46
Brown urine/hematuria
3
4
0.531
Medical histories
Hypertension
3
4
0.531
Coronary heart disease
1
1
0.588
Diabetes mellitus
2
1
0.194
Admission laboratory values
Creatinine (μmol/L)
68.6 ± 16.1
76.3 ± 20.0
0.119
BUN (mmol/L)
7.3 ± 2.1
7.2 ± 3.1
0.81
WBC (109/L)
8.1 ± 2.8
9.3 ± 2.6
0.091
Hematocrit (%)
43.3 ± 4.9
43.5 ± 6.2
0.878
Remifentanil dose during the first 24 hours of hospitalization (mg)
